Haleon plc cash flow statement
In fiscal 2025, Haleon plc's operations generated $3.47bn of cash; it spent $425m on capital projects, leaving free cash flow of $3.05bn.
Cash flow statement
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | 1,805 | 1,866 | 2,552 | 2,612 | 2,941 | 3,475 |
| Depreciation and amortisation | — | — | — | 384 | 414 | 475 |
| Stock-based pay | — | — | 19 | 95 | 130 | 113 |
| Capital spending | 285 | 314 | 376 | 291 | 320 | 425 |
| Free cash flow | 1,520 | 1,553 | 2,176 | 2,321 | 2,621 | 3,050 |
| Free cash flow after stock pay | — | — | 2,158 | 2,227 | 2,491 | 2,937 |
| Share buybacks | — | — | — | 47 | — | — |
Compare with peers
- Viatris cash flow
- Universe Pharmaceuticals Inc cash flow
- Bausch Health Companies Inc. cash flow
- Zoetis cash flow
- Organon & Co. cash flow
Head to head: HLN vs VTRSHLN vs UPCBHC vs HLNHLN vs ZTS
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies